Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

64.66
Delayed Data
As of Apr 24
 +0.84 / +1.32%
Today’s Change
55.06
Today|||52-Week Range
68.12
+3.26%
Year-to-Date
Breaking Down the 2-Stage Dividend Discount Model for Beginners
Apr 24 / GuruFocus News - Paid Partner Content
What's in Store for AbbVie (ABBV) this Earnings Season?
Apr 21 / Zacks.com - Paid Partner Content
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?
Apr 24 / Zacks.com - Paid Partner Content
What's in Store for Biogen (BIIB) this Earnings Season?
Apr 20 / Zacks.com - Paid Partner Content
EQT Midstream Partners, AbbVie, Blackstone Group: 'Mad Money' Lightning Round
Apr 21 / TheStreet.com - Paid Partner Content
AbbVie's (ABBV) Cancer Candidate Fails in Phase III Studies
Apr 20 / Zacks.com - Paid Partner Content
AbbVie's Veliparib Missed Primary Endpoints of 2 Clinical Trials
Apr 21 / GuruFocus News - Paid Partner Content
Europe And S&P Futures Higher, Dollar Drops As OPEC Talks Oil Up
Apr 20 / Investing Channel - Paid Partner Content
AbbVie (ABBV) Presents Positive Data on HCV Combination Drug
Apr 21 / Zacks.com - Paid Partner Content
Johnson & Johnson's Weak Pharma Revenue Could Spell Doom for Rest of Sector
Apr 18 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close63.82
Today’s open64.40
Day’s range64.26 - 65.16
Volume7,120,988
Average volume (3 months)6,467,434
Market cap$103.0B
Dividend yield3.96%
Data as of 04/24/2017

Growth & Valuation

Earnings growth (last year)+15.97%
Earnings growth (this year)+13.94%
Earnings growth (next 5 years)+12.10%
Revenue growth (last year)+12.16%
P/E ratio17.8
Price/Sales3.98
Price/Book22.21

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.34+0.83%
CELGCelgene+0.89+0.73%
LLYEli Lilly and Co+1.53+1.87%
----
Data as of 04/24/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$1.26
Annual revenue (last year)$25.6B
Annual profit (last year)$5.9B
Net profit margin23.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts


Search for Jobs